IGF1/IGF-1R promotes hepatocellular carcinoma progression by activating the Akt/GSK-3beta pathway. Liang J, Song X, Liu Y, Yang G, et al. PLoS One 2026;21:e0346926.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liang J, Song X, Liu Y, Yang G, et al. IGF1/IGF-1R promotes hepatocellular carcinoma progression by activating the Akt/GSK-3beta pathway. PLoS One 2026;21:e0346926.
PMID: 41955256